Jingfeng Pharmaceutical(SZ:000908) Xin Lang Cai Jing·2025-10-21 13:10Core Viewpoint - ST Jingfeng (000908.SZ) has received a court ruling accepting the reorganization application from creditors, indicating potential financial distress and the initiation of restructuring efforts [1] Group 1: Court Ruling and Management - The Changde Intermediate People's Court in Hunan Province has accepted the reorganization application for the company [1] - Beijing Zhonglun Law Firm has been appointed as the administrator for the company's restructuring process [1] Group 2: Stock Trading and Risk Warning - The company's stock will be subject to delisting risk warning starting from October 23, 2025, with the stock name changing to "*ST Jingfeng" while the stock code remains "000908" [1] - The daily price fluctuation limit for the stock will continue to be set at 5% [1] - The stock will be suspended from trading for one day on October 22, 2025, and will resume trading on October 23, 2025 [1]